Russel T Burge (R Burge, Russel Burge)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Systematic Review

Ejection Fraction

Top Venues

Advances in therapy

Patient preference and adherence

The Journal of rheumatology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jamie L W Rhoads, William N Malatestinic, Russel T Burge, Michael L Ganz, Kristina Callis Duffin
Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. Journal of psoriasis and psoriatic arthritis 9 (1) (2023)
Andrew Blauvelt, Nianwen Shi, Mwangi J Murage, Scott A Kern, Najwa Somani, Russel T Burge, Terri L Ridenour, Carolyn R Lew, Nicole M Zimmerman, Baojin Zhu
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings. Journal of medical economics 25 (1) (2022)
Wayne P Gulliver, Melinda J Gooderham, Baojin Zhu, Christian Jossart, Sonia Montmayeur, Russel T Burge, Catherine Reed
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program. Dermatology and therapy (2022)
Craig L Leonardi, Kyoungah See, Russel T Burge, Zhuoer Sun, Ying Zhang, Lotus Mallbris, Alyssa Garrelts, Richard Bruce Warren
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis. Advances in therapy 39 (5) (2022)
Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L McCollam, Theodore Spiro, Russel T Burge
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study. Advances in therapy (2021)
Robert L Ohsfeldt, Casey Kar-Chan Choong, Patrick L Mc Collam, Hamed Abedtash, Kari A Kelton, Russel T Burge
Inpatient Hospital Costs for COVID-19 Patients in the United States. Advances in therapy 38 (11) (2021)
D Rosmarin, S Smith, D Shrom, Russel T Burge, K See, M McKean-Matthews, T Ridenour, C-Y Lin, J Gorelick
Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non-responders: Subgroup analysis of UNCOVER-3 trial. Skin health and disease 1 (3) (2021)
Jashin J Wu, Ryan W Harrison, Baojin Zhu, Orin M Goldblum, William N Malatestinic, Russel T Burge, Mwangi J Murage
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry. Journal of comparative effectiveness research 10 (2) (2020)
Andrew Blauvelt, Nianwen Shi, Russel T Burge, William N Malatestinic, Chen-Yen Lin, Carolyn R Lew, Nicole M Zimmerman, Orin M Goldblum, Baojin Zhu, Mwangi J Murage
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab. Patient preference and adherence 14 (2020)
Andrew Blauvelt, C Leonardi, Boni E Elewski, J J Crowley, L C Guenther, Melinda J Gooderham, R G Langley, Ronald B Vender, Andreas Pinter, C E M Griffiths, Y Tada, H Elmaraghy, R G Lima, G Gallo, L Renda, Russel T Burge, S Y Park, B Zhu, Kim A Papp, null null
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. The British journal of dermatology 184 (6) (2020)
Alexander Egeberg, S Anderson, Emily Edson-Heredia, Russel T Burge
Comorbidities of alopecia areata: a population-based cohort study. Clinical and experimental dermatology 46 (4) (2020)
Peita L Graham-Clarke, Brett Hauber, Marco Boeri, Felice Leonardi, Russel T Burge, Maria Fernandez, Antje Tockhorn-Heidenreich, Sandra Flórez
Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia. Patient preference and adherence 14 (2020)
Alexander Egeberg, Y M F Andersen, Anne-Sofie Halling, F Alignahi, J P Thyssen, Russel T Burge, L Mallbris
Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (1) (2019)
Hasan Gökcer Tekin, Jashin J Wu, Russel T Burge, Julie A Birt, Alexander Egeberg
Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study. The Journal of rheumatology 46 (7) (2019)